BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 21865537)

  • 1. Long-term persistence of a polyclonal T cell repertoire after gene therapy for X-linked severe combined immunodeficiency.
    Gaspar HB; Cooray S; Gilmour KC; Parsley KL; Adams S; Howe SJ; Al Ghonaium A; Bayford J; Brown L; Davies EG; Kinnon C; Thrasher AJ
    Sci Transl Med; 2011 Aug; 3(97):97ra79. PubMed ID: 21865537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune Reconstitution After Gene Therapy Approaches in Patients With X-Linked Severe Combined Immunodeficiency Disease.
    Blanco E; Izotova N; Booth C; Thrasher AJ
    Front Immunol; 2020; 11():608653. PubMed ID: 33329605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell dynamics and response of the microbiota after gene therapy to treat X-linked severe combined immunodeficiency.
    Clarke EL; Connell AJ; Six E; Kadry NA; Abbas AA; Hwang Y; Everett JK; Hofstaedter CE; Marsh R; Armant M; Kelsen J; Notarangelo LD; Collman RG; Hacein-Bey-Abina S; Kohn DB; Cavazzana M; Fischer A; Williams DA; Pai SY; Bushman FD
    Genome Med; 2018 Sep; 10(1):70. PubMed ID: 30261899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lentivector cryptic splicing mediates increase in CD34+ clones expressing truncated HMGA2 in human X-linked severe combined immunodeficiency.
    De Ravin SS; Liu S; Sweeney CL; Brault J; Whiting-Theobald N; Ma M; Liu T; Choi U; Lee J; O'Brien SA; Quackenbush P; Estwick T; Karra A; Docking E; Kwatemaa N; Guo S; Su L; Sun Z; Zhou S; Puck J; Cowan MJ; Notarangelo LD; Kang E; Malech HL; Wu X
    Nat Commun; 2022 Jun; 13(1):3710. PubMed ID: 35764638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Therapies for Primary Immune Deficiencies.
    Kohn LA; Kohn DB
    Front Immunol; 2021; 12():648951. PubMed ID: 33717203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID.
    Cesana D; Cicalese MP; Calabria A; Merli P; Caruso R; Volpin M; Rudilosso L; Migliavacca M; Barzaghi F; Fossati C; Gazzo F; Pizzi S; Ciolfi A; Bruselles A; Tucci F; Spinozzi G; Pais G; Benedicenti F; Barcella M; Merelli I; Gallina P; Giannelli S; Dionisio F; Scala S; Casiraghi M; Strocchio L; Vinti L; Pacillo L; Draghi E; Cesana M; Riccardo S; Colantuono C; Six E; Cavazzana M; Carlucci F; Schmidt M; Cancrini C; Ciceri F; Vago L; Cacchiarelli D; Gentner B; Naldini L; Tartaglia M; Montini E; Locatelli F; Aiuti A
    Nat Commun; 2024 Apr; 15(1):3662. PubMed ID: 38688902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrome signatures of lentiviral gene therapy for SCID-X1 patients.
    Yan KK; Condori J; Ma Z; Metais JY; Ju B; Ding L; Dhungana Y; Palmer LE; Langfitt DM; Ferrara F; Throm R; Shi H; Risch I; Bhatara S; Shaner B; Lockey TD; Talleur AC; Easton J; Meagher MM; Puck JM; Cowan MJ; Zhou S; Mamcarz E; Gottschalk S; Yu J
    Sci Adv; 2023 Oct; 9(40):eadg9959. PubMed ID: 37801507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive B Cell Loss in Revertant X-SCID.
    Lin CH; Kuehn HS; Thauland TJ; Lee CM; De Ravin SS; Malech HL; Keyes TJ; Jager A; Davis KL; Garcia-Lloret MI; Rosenzweig SD; Butte MJ
    J Clin Immunol; 2020 Oct; 40(7):1001-1009. PubMed ID: 32681206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late-onset enteric virus infection associated with hepatitis (EVAH) in transplanted SCID patients.
    Riller Q; Fourgeaud J; Bruneau J; De Ravin SS; Smith G; Fusaro M; Meriem S; Magerus A; Luka M; Abdessalem G; Lhermitte L; Jamet A; Six E; Magnani A; Castelle M; Lévy R; Lecuit MM; Fournier B; Winter S; Semeraro M; Pinto G; Abid H; Mahlaoui N; Cheikh N; Florkin B; Frange P; Jeziorski E; Suarez F; Sarrot-Reynauld F; Nouar D; Debray D; Lacaille F; Picard C; Pérot P; Regnault B; Da Rocha N; de Cevins C; Delage L; Pérot BP; Vinit A; Carbone F; Brunaud C; Marchais M; Stolzenberg MC; Asnafi V; Molina T; Rieux-Laucat F; Notarangelo LD; Pittaluga S; Jais JP; Moshous D; Blanche S; Malech H; Eloit M; Cavazzana M; Fischer A; Ménager MM; Neven B
    J Allergy Clin Immunol; 2023 Jun; 151(6):1634-1645. PubMed ID: 36638922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoring T and B cell generation in X-linked severe combined immunodeficiency mice through hematopoietic stem cells adenine base editing.
    Zhang L; Li K; Liu Z; An L; Wei H; Pang S; Cao Z; Huang X; Jin X; Ma X
    Mol Ther; 2024 Mar; ():. PubMed ID: 38532630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term robustness of a T-cell system emerging from somatic rescue of a genetic block in T-cell development.
    Kury P; Führer M; Fuchs S; Lorenz MR; Giorgetti OB; Bakhtiar S; Frei AP; Fisch P; Boehm T; Schwarz K; Speckmann C; Ehl S
    EBioMedicine; 2020 Sep; 59():102961. PubMed ID: 32841837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe Combined Immunodeficiency (SCID) and Its New Treatment Modalities.
    Wadbudhe AM; Meshram RJ; Tidke SC
    Cureus; 2023 Oct; 15(10):e47759. PubMed ID: 38022338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Therapy for Inborn Errors of Immunity.
    Arlabosse T; Booth C; Candotti F
    J Allergy Clin Immunol Pract; 2023 Jun; 11(6):1592-1601. PubMed ID: 37084938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic stem cell gene therapy for adenosine deaminase-deficient severe combined immunodeficiency leads to long-term immunological recovery and metabolic correction.
    Gaspar HB; Cooray S; Gilmour KC; Parsley KL; Zhang F; Adams S; Bjorkegren E; Bayford J; Brown L; Davies EG; Veys P; Fairbanks L; Bordon V; Petropoulou T; Kinnon C; Thrasher AJ
    Sci Transl Med; 2011 Aug; 3(97):97ra80. PubMed ID: 21865538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A modified γ-retrovirus vector for X-linked severe combined immunodeficiency.
    Hacein-Bey-Abina S; Pai SY; Gaspar HB; Armant M; Berry CC; Blanche S; Bleesing J; Blondeau J; de Boer H; Buckland KF; Caccavelli L; Cros G; De Oliveira S; Fernández KS; Guo D; Harris CE; Hopkins G; Lehmann LE; Lim A; London WB; van der Loo JC; Malani N; Male F; Malik P; Marinovic MA; McNicol AM; Moshous D; Neven B; Oleastro M; Picard C; Ritz J; Rivat C; Schambach A; Shaw KL; Sherman EA; Silberstein LE; Six E; Touzot F; Tsytsykova A; Xu-Bayford J; Baum C; Bushman FD; Fischer A; Kohn DB; Filipovich AH; Notarangelo LD; Cavazzana M; Williams DA; Thrasher AJ
    N Engl J Med; 2014 Oct; 371(15):1407-17. PubMed ID: 25295500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy for PIDs: progress, pitfalls and prospects.
    Mukherjee S; Thrasher AJ
    Gene; 2013 Aug; 525(2):174-81. PubMed ID: 23566838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome.
    Aiuti A; Biasco L; Scaramuzza S; Ferrua F; Cicalese MP; Baricordi C; Dionisio F; Calabria A; Giannelli S; Castiello MC; Bosticardo M; Evangelio C; Assanelli A; Casiraghi M; Di Nunzio S; Callegaro L; Benati C; Rizzardi P; Pellin D; Di Serio C; Schmidt M; Von Kalle C; Gardner J; Mehta N; Neduva V; Dow DJ; Galy A; Miniero R; Finocchi A; Metin A; Banerjee PP; Orange JS; Galimberti S; Valsecchi MG; Biffi A; Montini E; Villa A; Ciceri F; Roncarolo MG; Naldini L
    Science; 2013 Aug; 341(6148):1233151. PubMed ID: 23845947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Therapy for X-Linked Severe Combined Immunodeficiency: Where Do We Stand?
    Cavazzana M; Six E; Lagresle-Peyrou C; André-Schmutz I; Hacein-Bey-Abina S
    Hum Gene Ther; 2016 Feb; 27(2):108-16. PubMed ID: 26790362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years.
    Blaese RM; Culver KW; Miller AD; Carter CS; Fleisher T; Clerici M; Shearer G; Chang L; Chiang Y; Tolstoshev P; Greenblatt JJ; Rosenberg SA; Klein H; Berger M; Mullen CA; Ramsey WJ; Muul L; Morgan RA; Anderson WF
    Science; 1995 Oct; 270(5235):475-80. PubMed ID: 7570001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency.
    De Ravin SS; Wu X; Moir S; Anaya-O'Brien S; Kwatemaa N; Littel P; Theobald N; Choi U; Su L; Marquesen M; Hilligoss D; Lee J; Buckner CM; Zarember KA; O'Connor G; McVicar D; Kuhns D; Throm RE; Zhou S; Notarangelo LD; Hanson IC; Cowan MJ; Kang E; Hadigan C; Meagher M; Gray JT; Sorrentino BP; Malech HL; Kardava L
    Sci Transl Med; 2016 Apr; 8(335):335ra57. PubMed ID: 27099176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.